Thomas J. Riga - 31 Dec 2022 Form 5 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role
CEO & President, Director
Signature
/s/ Keith M. McGahan, Attorney-in-Fact for Thomas J. Riga
Issuer symbol
N/A
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
13 Feb 2023, 16:31:26 UTC
Previous filing
23 Jun 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +239,500 +25% $0.000000 1,213,340 14 Feb 2022 Direct F1, F2
holding SPPI Common Stock, $0.001 par value 14,139 31 Dec 2022 By 401(k) plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock award grant was approved by Spectrum Pharmaceuticals, Inc.'s board of directors on February 14, 2022 with an issuance date of January 14, 2022.
F2 One third of the amount of restricted shares shall vest on each of December 30, 2022, 2023 and 2024, respectively.